Cancer Gene Therapy
Transfection of Chronic Lymphocytic Leukemia B Cells Possible
Published in Gene Therapy Weekly, January 27th, 1997
B-cell CLL is the most common adult leukemia, and despite recent therapeutic advances, is still not considered curable. There are many reasons why CLL should be amenable to gene therapy, however, it is a leukemia of 'resting' B cells, and therefore not easily infected by retroviruses. This disease also has been shown to be resistant to most other currently available gene transfer techniques (e.g., electroporation, lipofectin, or amphotropic retrovirus infection).
In light of the potential role of gene transfer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1997-01-27)
More Articles from Gene Therapy Weekly
- Corrective Gene Therapy (CGD)
Gene Transfer Corrects Defect in Host Defense against Infection - Antisense Technology
Anticancer Drug Demonstrates Antitumor Activity In Vivo - Antisense Technology
Compound Aimed at Reducing Serum Cholesterol Levels - Breast Cancer
'Switched On' Gene in Cancer Cells Remains 'Turned Off' in Normal Tissue - Breast Cancer
Random Homozygous Knockout Method Discovers Cancer Gene - Industry News (Joint Venture)
Collaboration Established for Combinatorial Drug Discovery - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
